Third PRORISK Newsletter

The third PRORISK Newsletter is available. A selection of published results is presented in this scientific newsletter with the contribution to Adverse outcome pathways (AOPs) of novel Flame Retardants (nFRs) and Chitin Synthase inhibitors.

April 2022 Newsletter

No description

Newsletter website

More articles

All articles

You are running an old browser version. We recommend updating your browser to its latest version.

More info